Avemedica

Avemedica is a life sciences company specializing in the development and commercialization of products based on avenanthramides, which are potent anti-inflammatory polyphenols found in oats. Originally founded as a Swiss biotechnology firm, the company focused on developing synthetic avenanthramide analogs to treat human inflammatory conditions such as atopic dermatitis and psoriasis by inhibiting the NF-kappaB pathway. While its human pharmaceutical programs remain in the pre-clinical stage, Avemedica has successfully transitioned to the veterinary market, offering a range of science-based equine supplements. These products, marketed under the Avemedica brand, target gastrointestinal health, joint support, and muscle recovery in performance horses. The company is led by industry veterans with extensive experience in pharmaceutical R&D and animal health.